Governance Gilead Sciences, Inc.

GILD

US3755581036

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 19:27:28 13/09/2024 BST			5-day change	1st Jan Change
82.44 ^USD	+0.05%		+4.85%	+1.88%

01:00pm	Marengo Therapeutics, Inc. Announces Clinical Study Collaboration with Gilead Sciences to Evaluate Invikafusp alfa and Trodelvy in Both Metastatic TNBC and Metastatic HR+/HER2- Breast Cancers	CI
09-12	Gilead Sciences Says Twice-Yearly HIV Treatment Lenacapavir Reduces Infections by 96%	MT

Executive Committee: Gilead Sciences, Inc.

Manager

Positions heldSince

Daniel O'Day

59 year

Chief Executive Officer

28/02/2019

Sarah Miksinski

General Counsel

Sandra Patterson

57 year

Comptroller/Controller/Auditor

28/02/2023

Deborah Telman

59 year

General Counsel	31/07/2022
Corporate Secretary	31/07/2022

Flavius Martin

Chief Tech/Sci/R&D Officer

11/04/2021

Jacquie Ross

Investor Relations Contact

31/12/2020

Merdad Parsey

61 year

Chief Tech/Sci/R&D Officer

31/10/2019

Jyoti Mehra

48 year

Human Resources Officer

31/10/2017

Andrew Dickinson

54 year

Director of Finance/CFO

31/10/2019

Composition of the Board of Directors: Gilead Sciences, Inc.

Director

CommitteesSince

Daniel O'Day

59 year

Chairman

28/02/2019

Anthony Welters

69 year

Governance Committee
Nominating Committee
Compensation Committee Chair	26/10/2015
Compensation Committee	16/10/2020
HR Committee	16/10/2020
Governance Committee Chair	11/05/2021
Nominating Committee Chair	11/05/2021

Harish M. Manwani

70 year

HR Committee	08/05/2018
Governance Committee	11/05/2021
Nominating Committee	11/05/2021
Compensation Committee	08/05/2018

Ted Love

65 year

Governance Committee Chair
Nominating Committee Chair
Compensation Committee Chair	02/08/2023
Audit Committee	31/01/2024

Kelly Kramer

56 year

Compensation Committee	30/11/2020
HR Committee
Audit Committee Chair	30/11/2020
Audit Committee	31/01/2020

Sandra Horning

75 year

Governance Committee	27/01/2020
Nominating Committee	27/01/2020

Jacqueline Barton

71 year

Compensation Committee	31/12/2017
HR Committee	31/12/2017

Javier Rodriguez

53 year

Audit Committee

14/06/2020

Jeffrey Bluestone

70 year

Executive Committee

08/04/2020

Latest Appointments: Gilead Sciences, Inc.

Cytokinetics, Incorporated Announces the Appointment of Brett Pletcher as Executive Vice President and Chief Legal Officer	08-15	CI
Fate Therapeutics, Inc. Appoints Neely Mozaffarian to its Board of Directors	07-31	CI
Gilead Sciences Chief Medical Officer Merdad Parsey to Leave	07-17	MT
Gilead Sciences Chief Medical Officer to Step Down	07-17	DJ
Merdad Parsey to Leave Gilead Sciences, Inc. as Chief Medical Officer, Effective Early 2025	07-17	CI
Sector Update: Health Care Stocks Rise Tuesday Afternoon	06-04	MT
Gilead Sciences, Inc. Announces Retirement of Kevin E. Lofton from the Board, Effective May 8, 2024	03-14	CI

More news

Former Officers and Directors: Gilead Sciences, Inc.

Insider

Positions held

SinceUntil

Kevin Lofton

Director/Board Member	28/07/2009	07/05/2024
Independent Dir/Board Member	28/07/2009	07/05/2024

Brett Pletcher

Compliance Officer	-	31/07/2022
General Counsel	30/03/2011	31/07/2022
Corporate Officer/Principal	31/12/2004	30/03/2011
Corporate Secretary	-	31/07/2022

Tai Yin Yang

Corporate Officer/Principal

31/12/2004

17/07/2022

Amy E. Flood

Public Communications Contact

31/05/2021

William Lee

Chief Tech/Sci/R&D Officer

31/12/1990

11/04/2021

Richard Whitley

Director/Board Member	30/06/2008	31/12/2020
Independent Dir/Board Member	30/06/2008	31/12/2020

Robin Washington

Comptroller/Controller/Auditor	04/05/2008	31/10/2019
Director of Finance/CFO	04/05/2008	31/10/2019

Gregg Alton

Chief Executive Officer	31/12/2018	28/02/2019
Compliance Officer	31/12/1998	-
Public Communications Contact	03/08/2009	08/05/2012
General Counsel	31/12/1998	03/08/2009
Corporate Officer/Principal	28/02/2019	03/10/2019
Corporate Secretary	31/12/1998	-

John McHutchison

Chief Tech/Sci/R&D Officer	28/02/2018	01/08/2019
Corporate Officer/Principal	07/06/2010	28/02/2018

John Martin

Chief Executive Officer	31/12/1995	09/03/2016
Chairman	31/05/2008	28/02/2019

John Milligan

Director/Board Member	27/01/2016	30/12/2018
Chief Executive Officer	09/03/2016	30/12/2018
Chief Operating Officer	31/12/2006	09/03/2016
President	31/12/2007	30/12/2018

Andrew Cheng

Chief Tech/Sci/R&D Officer	-	06/09/2018
Corporate Officer/Principal	31/12/1998	-

Norbert W. Bischofberger

Chief Tech/Sci/R&D Officer	31/12/1994	29/04/2018
Corporate Officer/Principal	31/07/1990	31/12/1994

James Meyers

Corporate Officer/Principal

31/12/1995

21/02/2018

John Madigan

Director/Board Member	30/11/2005	09/05/2017
Independent Dir/Board Member	21/07/2011	09/05/2017

Paul Carter

Corporate Officer/Principal

31/03/2006

31/07/2016

Kevin B. Young

Corporate Officer/Principal	31/08/2004	03/02/2014
Chief Operating Officer	23/05/2016	-

Gordon Earle Moore

Director/Board Member	31/12/1995	30/05/2013
Independent Dir/Board Member	21/07/2011	30/05/2013

James M. Denny

Director/Board Member	31/12/1995	30/05/2013
Independent Dir/Board Member	21/07/2011	30/05/2013

Susan T. Hubbard

Investor Relations Contact

31/08/1989

31/05/2012

Alan Montgomery

Corporate Officer/Principal

31/07/2006

30/04/2011

Anthony D. Caracciolo

Corporate Officer/Principal

31/12/1996

30/09/2010

Per Wold-Olsen

Director/Board Member	27/01/2010	-
Independent Dir/Board Member	27/01/2010	-

Louis Lange

Corporate Officer/Principal

19/04/2009

Seigo Izumo

Corporate Officer/Principal

31/08/2008

Caroline Dorsa

Director of Finance/CFO

04/11/2007

16/01/2008

Howard Rosen

Corporate Officer/Principal

31/12/2003

31/12/2007

Carla A. Hills

Director/Board Member	31/12/2006	-
Independent Dir/Board Member	21/07/2011	-

Kristen M. Metza

Human Resources Officer

31/12/2005

Steven Fife

Comptroller/Controller/Auditor

31/12/2004

31/12/2005

John Francis Cogan

Director/Board Member	30/06/2005	-
Independent Dir/Board Member	30/06/2005	-

Nicholas G. Moore

Director/Board Member	29/02/2004	-
Independent Dir/Board Member	29/02/2004	-

Karl G. Trass

General Counsel

31/12/2002

30/06/2003

James Sapirstein

Sales & Marketing

31/05/2000

31/05/2002

Rebecca Coleman

Director/Board Member

01/01/2000

Michael W. Aguiar

Director of Finance/CFO

31/12/2001

Robert L. Simon

General Counsel

30/06/2000

30/11/2001

Gayle Edlund Wilson

Director/Board Member	30/09/2001	-
Independent Dir/Board Member	30/09/2001	-

Jeff Bird

Corporate Officer/Principal

31/12/1999

Kenneth Cundy

Corporate Officer/Principal

31/12/1991

31/12/1999

Mark D. Matteucci

Corporate Officer/Principal

31/12/1987

31/12/1998

Louis C. Bock

Corporate Officer/Principal

31/08/1989

Robert J. Stagg

Chief Tech/Sci/R&D Officer

31/07/1993

30/11/1996

Bill Harris

Director of Finance/CFO

31/12/1989

31/12/1995

Michael Bigham

Chief Operating Officer	31/12/1987	31/12/1995
Director of Finance/CFO	31/12/1987	31/12/1995

George Pratt Shultz

Director/Board Member

31/12/1995

John Latham

Corporate Officer/Principal

31/12/1988

31/12/1993

Étienne Francois Davignon

Director/Board Member	31/08/1990	-
Independent Dir/Board Member	21/07/2011	-

John J. Toole

Corporate Officer/Principal

31/03/1990

Akram Bouchenaki

Corporate Officer/Principal

Nicholas S. Hellmann

Corporate Officer/Principal

Joseph M. Baini

Corporate Officer/Principal

Wenjin Yang

Corporate Officer/Principal

James V. Desiderio

Corporate Officer/Principal

Jim Ziegler

Sales & Marketing

George Tidmarsh

Corporate Officer/Principal

Erin Edgley

Public Communications Contact

Patrick O'Brien

Investor Relations Contact

Sunil Patel

Corporate Officer/Principal

Dirk B. Mendel

Corporate Officer/Principal

Jeffrey Rudy

Corporate Officer/Principal

Gulshan H. Shaver

Corporate Officer/Principal

Gary C. Visor

Corporate Officer/Principal

Roger G. Mills

Corporate Officer/Principal

Julie Cherrington

Corporate Officer/Principal

Cordell W. Hull

Director/Board Member

David Brogan

Corporate Officer/Principal

Jeffery P. Davis

Corporate Officer/Principal

Mark Italia

General Counsel

Richard J. Gorczynski

Corporate Officer/Principal

Pamela Goss

Corporate Officer/Principal

Adam Tomasi

Corporate Officer/Principal

Robert L. St. Claire

Corporate Officer/Principal

Age distribution of managers

Parity Men Women

Male	22
Female	10

Of which Executive Committee

Male	5
Female	4

Of which Directors

Male	8
Female	1

ESG Refinitiv

B-

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Gilead Sciences, Inc. specializes in the development, manufacturing and marketing of therapeutic products. Net sales break down by source of income as follows: - sale of drugs (98.9%): for the treatment of HIV (63% of net sales), COVID-19 (20.4%), hepatitis C virus (6.6%), hepatitis B virus (3.6%) and other (6.4%; primarily cytomegalovirus retinitis, and advanced Kaposi sarcoma resulting from HIV); - other (1.1%): especially royalties and revenue from research and development services and from subcontracted production of therapeutic products. Net sales are distributed geographically as follows: the United States (69.2%), Europe (16.4%) and other (14.4%).

Employees

18,000

Sector

Pharmaceuticals

Calendar

12/09/2024 - Détachement de

More about the company

Departures of Key Persons

Donald H. Rumsfeld

Chairman

02/01/1997 -

John Milligan

Chief Executive Officer

09/03/2016 30/12/2018

John Martin

Chief Executive Officer

31/12/1995 09/03/2016

Gregg Alton

Chief Executive Officer

31/12/2018 28/02/2019

Governance Gilead Sciences, Inc.

Equities

GILD

US3755581036

Pharmaceuticals

Executive Committee: Gilead Sciences, Inc.

Composition of the Board of Directors: Gilead Sciences, Inc.

Latest Appointments: Gilead Sciences, Inc.

Former Officers and Directors: Gilead Sciences, Inc.

Age distribution of managers

Parity Men Women

Environment

Governance

Controversy

Company Profile

Departures of Key Persons

Governance Gilead Sciences, Inc.

Equities

GILD

US3755581036

Pharmaceuticals

Executive Committee: Gilead Sciences, Inc.

Composition of the Board of Directors: Gilead Sciences, Inc.

Latest Appointments: Gilead Sciences, Inc.

Former Officers and Directors: Gilead Sciences, Inc.

Age distribution of managers

Parity Men Women

Environment

Social

Governance

Controversy

Company Profile

Departures of Key Persons